NCT01519674 - Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and Metformin | Biotech Hunter

Enrollment

582

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

biphasic insulin aspart 30

BIAsp 30 will be injected subcutaneously (under the skin) twice daily. Individually adjusted dose.

DRUG

biphasic insulin aspart 30

BIAsp 30 will be injected subcutaneously (under the skin) once daily. Individually adjusted dose.

DRUG

sitagliptin

Subjects will continue on their pre-trial sitagliptin treatment.

DRUG

metformin

Subjects will continue on their pre-trial metformin treatment.

Trial Locations (69)

2292

Novo Nordisk Investigational Site, Broadmeadow

2450

Novo Nordisk Investigational Site, Coffs Harbour

10330

Novo Nordisk Investigational Site, Bangkok

10380

Novo Nordisk Investigational Site, Goyang

10400

Novo Nordisk Investigational Site, Bangkok

10459

Novo Nordisk Investigational Site, George Town

16247

Novo Nordisk Investigational Site, Suwon

34371

Novo Nordisk Investigational Site, Istanbul

34718

Novo Nordisk Investigational Site, Istanbul

34722

Novo Nordisk Investigational Site, Istanbul

34890

Novo Nordisk Investigational Site, Istanbul

40002

Novo Nordisk Investigational Site, Khon Kaen

50200

Novo Nordisk Investigational Site, Chiang Mai

70300

Novo Nordisk Investigational Site, Seremban

110001

Novo Nordisk Investigational Site, New Delhi

143001

Novo Nordisk Investigational Site, Amritsar

201301

Novo Nordisk Investigational Site, Noida

208005

Novo Nordisk Investigational Site, Kanpur

221105

Novo Nordisk Investigational Site, Varanasi

380006

Novo Nordisk Investigational Site, Ahmedabad

380016

Novo Nordisk Investigational Site, Ahmedabad

440010

Novo Nordisk Investigational Site, Nagpur

500003

Novo Nordisk Investigational Site, Hyderabad

500034

Novo Nordisk Investigational Site, Hyderabad

500082

Novo Nordisk Investigational Site, Hyderabad

530002

Novo Nordisk Investigational Site, Visakhapatnam

560002

Novo Nordisk Investigational Site, Bangalore

560043

Novo Nordisk Investigational Site, Bangalore

560092

Novo Nordisk Investigational Site, Bangalore

600003

Novo Nordisk Investigational Site, Chennai

600006

Novo Nordisk Investigational Site, Chennai

600040

Novo Nordisk Investigational Site, Chennai

620018

Novo Nordisk Investigational Site, Trichy

641009

Novo Nordisk Investigational Site, Coimbatore

673016

Novo Nordisk Investigational Site, Calicut

695607

Novo Nordisk Investigational Site, Trivandrum

700019

Novo Nordisk Investigational Site, Kolkata

700038

Novo Nordisk Investigational Site, Kolkata

B1704ETD

Novo Nordisk Investigational Site, Buenos Aires

C1250AAN

Novo Nordisk Investigational Site, Buenos Aires

C1179AAB

Novo Nordisk Investigational Site, Caba

C1440AAD

Novo Nordisk Investigational Site, Caba

B7600FZN

Novo Nordisk Investigational Site, Mar del Plata

B1708IFF

Novo Nordisk Investigational Site, Morón

01244-030

Novo Nordisk Investigational Site, São Paulo

71625-009

Novo Nordisk Investigational Site, Brasília

80810-040

Novo Nordisk Investigational Site, Curitiba

60430-350

Novo Nordisk Investigational Site, Fortaleza

90035-170

Novo Nordisk Investigational Site, Porto Alegre

GR-68100

Novo Nordisk Investigational Site, Alexandroupoli

151 23

Novo Nordisk Investigational Site, Athens

GR-17562

Novo Nordisk Investigational Site, Athens

GR-54642

Novo Nordisk Investigational Site, Thessaloniki

GR-57001

Novo Nordisk Investigational Site, Thessaloniki

GR-57010

Novo Nordisk Investigational Site, Thessaloniki

560 017

Novo Nordisk Investigational Site, Bangalore

3000-561

Novo Nordisk Investigational Site, Coimbra

1250-230

Novo Nordisk Investigational Site, Lisbon

1500-650

Novo Nordisk Investigational Site, Lisbon

1649-035

Novo Nordisk Investigational Site, Lisbon

4464-513

Novo Nordisk Investigational Site, Matosinhos Municipality

4200-319

Novo Nordisk Investigational Site, Porto

561-712

Novo Nordisk Investigational Site, Jeonju

602-739

Novo Nordisk Investigational Site, Pusan

431-796

Novo Nordisk Investigational Site, Pyungchon-Dong 896, Dongan-Gu

03080

Novo Nordisk Investigational Site, Seoul

150-713

Novo Nordisk Investigational Site, Seoul

682-060

Novo Nordisk Investigational Site, Ulsan

07058

Novo Nordisk Investigational Site, Antalya